ImmunoPrecise Antibodies Ltd.
IPA
$0.3918
-$0.0082-2.05%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.47% | 12.56% | -45.73% | 7.04% | -15.31% |
| Total Receivables | 49.46% | -21.91% | -2.55% | -8.02% | -2.89% |
| Inventory | 6.61% | -13.06% | -17.76% | 7.19% | 4.99% |
| Prepaid Expenses | -4.62% | 21.55% | -25.63% | 1.50% | -3.55% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 12.47% | -4.56% | -25.73% | 1.45% | -7.18% |
|
|
|||||
| Total Current Assets | 12.47% | -4.56% | -25.73% | 1.45% | -7.18% |
| Net Property, Plant & Equipment | -3.76% | -2.04% | -1.79% | 44.80% | -8.82% |
| Long-term Investments | 0.04% | 1.57% | -59.91% | 2.39% | -4.33% |
| Goodwill | 0.04% | 1.57% | -59.91% | 2.39% | -4.33% |
| Total Other Intangibles | -2.64% | -1.06% | -17.64% | -0.12% | -6.64% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 1.45% | -5.36% | 25.60% | 6.55% |
| Total Assets | 0.24% | -1.64% | -25.79% | 8.04% | -6.50% |
|
|
|||||
| Total Accounts Payable | -21.35% | 10.35% | 24.06% | 22.25% | 9.02% |
| Total Accrued Expenses | 494.71% | -65.00% | -48.11% | 18.64% | 7.98% |
| Short-term Debt | 17.97% | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.59% | 2.17% | -13.95% | 92.39% | -13.28% |
| Total Finance Division Other Current Liabilities | 4.61% | 30.94% | -36.86% | 6.13% | 30.31% |
| Total Other Current Liabilities | 4.61% | 30.94% | -36.86% | 6.13% | 30.31% |
| Total Current Liabilities | 10.09% | 36.84% | -12.95% | 25.18% | 11.14% |
|
|
|||||
| Total Current Liabilities | 10.09% | 36.84% | -12.95% | 25.18% | 11.14% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 17.97% | -- | -- | -- | -- |
| Capital Leases | -2.76% | -2.32% | -6.55% | 52.02% | -6.94% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -5.81% | -42.33% | -20.82% | 0.16% | -6.83% |
| Total Liabilities | 2.28% | 0.94% | -12.10% | 27.12% | -1.80% |
|
|
|||||
| Common Stock & APIC | 0.77% | -0.01% | -1.42% | 4.70% | -5.07% |
| Retained Earnings | -1.59% | -1.77% | -18.71% | -7.66% | 2.04% |
| Treasury Stock & Other | 5.61% | 27.60% | 28.09% | -17.09% | 29.53% |
| Total Common Equity | -1.41% | -3.63% | -33.72% | -0.61% | -8.48% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.41% | -3.63% | -33.72% | -0.61% | -8.48% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.41% | -3.63% | -33.72% | -0.61% | -8.48% |
|
|
|||||
